Molecular Dissection of the Permeability Transition Pore
Molecular Dissection of the Permeability Transition Pore
批准号:
6872901
负责人:
MICHAEL A FORTE
金额:
$31.31万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-04-01 至 2008-03-31
中文摘要
描述(申请人提供):线粒体在细胞存活和组织发育中发挥关键作用,其作用包括能量代谢、细胞ca2 +稳态调节和细胞凋亡。考虑到这种多因素作用,ca2 +稳态、代谢和生物能量学作为一个综合系统起作用,因为能量守恒用于驱动每个过程。线粒体能量守恒(ATP的产生)需要呼吸驱动的质子电化学电位差(δ mu H)在线粒体内膜(IMM)上形成,这是由呼吸复合体的质子泵送产生的。维持梯度要求IMM对质子、带电物质和溶质的低渗透性。然而,体外的线粒体很容易对分子质量约为1,500 Da或更低的溶质进行IMM渗透性增加。这种渗透性变化被称为渗透性过渡(PT),是由细胞膜孔(线粒体渗透性过渡孔(PTP))的打开来调节的。体外PTP打开对线粒体功能(例如,δ mu H的崩溃和吡啶核苷酸的消耗)和结构(细胞色素c的释放)产生显著影响,从而导致呼吸抑制。长期以来,这一过程一直被研究为体内线粒体功能障碍的潜在靶点,并通过释放细胞色素c和其他在凋亡机制中活跃的膜间蛋白作为程序性细胞死亡(PCD)的介质。然而,尽管在过去的30年里对PTP进行了详细的功能表征,但形成PTP的分子成分尚未明确确定,PTP在体内的确切作用也尚未确定。这一建议是基于通过结合我们两个实验室可用的新方法可能产生的协同作用。我们的具体计划包括以下目标:目标1:在筛选PTP的化学抑制剂中,我们通过对哺乳动物VDAC (VDAC1)异构体1的共价修饰,在功能分析中发现Ro 68-3400是PTP的高亲和力(nM)阻断剂。类似的实验也证明了这种化合物是酵母VDAC1的特异性靶点。我们计划利用我们在哺乳动物和酵母VDAC上的经验来确定VDAC与该化合物高亲和关联的结构要求,检查其他哺乳动物VDAC同工型被Ro 68-3400修饰的能力,并测试用这种新型PTP阻断剂处理的线粒体对BCL-2家族蛋白质的敏感性。目的2:传统上,PTP被认为是一种动态的多蛋白复合物,通过IMM的腺嘌呤核苷酸转运子(ANT)、OMM中的VDAC和基质调节蛋白线粒体亲环蛋白D (CyP-D)的相互作用,在膜内外接触位点形成。然而,最近的数据并没有支持ANT参与PTP复合体的证据。因此,在这个目标中,我们计划利用Ro 68-3400作为一个特定的工具来进一步定义形成PTP的核心成分,并特别关注于识别孔隙复合体中VDAC的IMM伙伴。目的3:环孢素A (CsA)和非免疫抑制类似物的抑制作用已成为鉴定分离线粒体、活细胞和体内PTP的标准诊断工具。在这些研究中,CsA的靶标CyP-D是PTP中唯一被明确确定作用的成分。该目的的目标是通过使用通过“敲除”策略消除cypd和MVDAC1表达的小鼠,明确解决与cypd对PTP的影响、PTP参与凋亡程序的特定方面以及其在对人类疾病有重要意义的特定病理过程中的作用相关的基本问题。
英文摘要
DESCRIPTION (provided by applicant): Mitochondria play a pivotal role in cell survival and tissue development by virtue of their role in energy metabolism, regulation of cellular Ca 2+ homeostasis and apoptosis. Given this multifactorial role, Ca 2+ homeostasis, metabolism, and bioenergetics function as an integrated system since energy conservation is used to drive each process. Mitochondrial energy conservation (ATP production) requires the respiration-driven formation of a proton electrochemical potential difference (delta mu H) across the inner mitochondrial membrane (IMM), which is created by proton pumping by the respiratory complexes. Maintenance of the gradient demands a low permeability of the IMM to protons, charged species and solutes. Yet, mitochondria in vitro can easily undergo an IMM permeability increase to solutes with molecular masses of about 1,500 Da or lower. This permeability change, called the permeability transition (PT), is regulated by the opening of a membrane pore, the mitochondrial permeability transition pore (PTP). PTP opening in vitro has dramatic consequences on mitochondrial function (e.g., collapse of the delta mu H and depletion of pyridine nucleotides) and structure (release of cytochrome c) that lead to respiratory inhibition. This process has long been studied as a potential target for mitochondrial dysfunction in vivo and as a mediator of programmed cell death (PCD) through the release of cytochrome c and other intermembrane proteins active on the apoptotic machinery. However, despite detailed functional characterization over the last 30 years, the molecular components forming the PTP have been not been definitively established nor has the precise role of the PTP in vivo been defined. This proposal is based in the synergy possible through the combination of novel approaches available in our two laboratories. Our specific plans include the following aims: Aim 1: In screens for chemical inhibitors of the PTP, we have identified Ro 68-3400 in functional assays as a high affinity (nM) blocker of the PTP through covalent modification of isoform 1 of mammalian VDAC (VDAC1). Similar experiments have also demonstrated that yeast VDAC1 is specifically targeted by this compound. We plan to use our experience with both mammalian and yeast VDAC to pin-point the structural requirements for high affinity association of VDAC with this compound, examine other mammalian VDAC isoforms for their ability to be modified by Ro 68-3400 and test the sensitivity of mitochondria treated with this novel PTP blocker to proteins in the BCL-2 family. Aim 2: Traditionally, the PTP has been considered to be a dynamic multiprotein complex formed at inner/outer membrane contact sites through the interaction of the adenine nucleotide translocator (ANT) of the IMM, VDAC in the OMM and a matrix regulatory protein, mitochondrial cyclophilin D (CyP-D). However, evidence implicating the ANT in the PTP complex has not been supported by recent data. Therefore, in this aim we plan to take advantage of Ro 68-3400 as a specific tool to further define the core components forming the PTP, with a specific focus on the identification of the IMM partner for VDAC in the pore complex. Aim 3: Inhibition by cyclosporin A (CsA) and non-immunosuppressive analogs has become the standard diagnostic tool for the characterization of the PTP in isolated mitochondria, in living cells, and in vivo. The target of CsA in these studies, CyP-D, is the only component of the PTP whose role has been definitively established. The goal of this aim is to unambiguously resolve basic questions related to the influence of CyP-D on the PTP, the participation of the PTP in specific aspects of the apoptotic program, and its role in specific pathological processes of significance to human, disease through the use of mice in which the expression of CyP-D and MVDAC1 have been eliminated by "knock-out" strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Dissection of the Permeability Transition Pore
-
批准号:7028266
-
项目类别:
-
资助金额:$30.52万
-
财政年份:2004
-
负责人:MICHAEL A FORTE
-
依托单位:
Molecular Structure and Regulation of the Permeability Transition Pore
-
批准号:8667462
-
项目类别:
-
资助金额:$31.04万
-
财政年份:2004
-
负责人:MICHAEL A FORTE
-
依托单位:
Molecular Dissection of the Permeability Transition Pore
-
批准号:6712324
-
项目类别:
-
资助金额:$32.64万
-
财政年份:2004
-
负责人:MICHAEL A FORTE
-
依托单位:
Molecular Structure and Regulation of the Permeability Transition Pore
-
批准号:8370446
-
项目类别:
-
资助金额:$32.39万
-
财政年份:2004
-
负责人:MICHAEL A FORTE
-
依托单位:
Molecular Structure and Regulation of the Permeability Transition Pore
-
批准号:7729756
-
项目类别:
-
资助金额:$34.15万
-
财政年份:2004
-
负责人:MICHAEL A FORTE
-
依托单位:
Molecular Dissection of the Permeability Transition Pore
-
批准号:7214064
-
项目类别:
-
资助金额:$29.58万
-
财政年份:2004
-
负责人:MICHAEL A FORTE
-
依托单位:
Molecular Structure and Regulation of the Permeability Transition Pore
-
批准号:8538416
-
项目类别:
-
资助金额:$29.95万
-
财政年份:2004
-
负责人:MICHAEL A FORTE
-
依托单位:
Gs signaling in synaptic development and function
-
批准号:6542160
-
项目类别:
-
资助金额:$28.69万
-
财政年份:2002
-
负责人:MICHAEL A FORTE
-
依托单位:
Gs signaling in synaptic development and function
-
批准号:6908281
-
项目类别:
-
资助金额:$28.69万
-
财政年份:2002
-
负责人:MICHAEL A FORTE
-
依托单位:
Gs signaling in synaptic development and function
-
批准号:6750167
-
项目类别:
-
资助金额:$28.69万
-
财政年份:2002
-
负责人:MICHAEL A FORTE
-
依托单位:
Gs signaling in synaptic development and function
-
批准号:7082023
-
项目类别:
-
资助金额:$28.02万
-
财政年份:2002
-
负责人:MICHAEL A FORTE
-
依托单位:
Gs signaling in synaptic development and function
-
批准号:6616138
-
项目类别:
-
资助金额:$28.69万
-
财政年份:2002
-
负责人:MICHAEL A FORTE
-
依托单位:
MITOCHONDRIAL CYCLOPHILIN IN CELL DEATH PATHWAYS
-
批准号:6164834
-
项目类别:
-
资助金额:$9.45万
-
财政年份:1999
-
负责人:MICHAEL A FORTE
-
依托单位:
MITOCHONDRIAL CYCLOPHILILN IN CELL DEATH PATHWAYS
-
批准号:2740017
-
项目类别:
-
资助金额:$10.43万
-
财政年份:1999
-
负责人:MICHAEL A FORTE
-
依托单位:
GS PATHWAYS IN DROSOPHILA EPITHELIAL CELLS
-
批准号:6181187
-
项目类别:
-
资助金额:$23.92万
-
财政年份:1997
-
负责人:MICHAEL A FORTE
-
依托单位:
GS PATHWAYS IN DROSOPHILA EPITHELIAL CELLS
-
批准号:6019279
-
项目类别:
-
资助金额:$23.24万
-
财政年份:1997
-
负责人:MICHAEL A FORTE
-
依托单位:
GS PATHWAYS IN DROSOPHILA EPITHIAL CELLS
-
批准号:2771082
-
项目类别:
-
资助金额:$22.58万
-
财政年份:1997
-
负责人:MICHAEL A FORTE
-
依托单位:
GS PATHWAYS IN DROSOPHILA EPITHIAL CELLS
-
批准号:2024331
-
项目类别:
-
资助金额:$21.75万
-
财政年份:1997
-
负责人:MICHAEL A FORTE
-
依托单位:
G PROTEINS IN THE CNS
-
批准号:3414058
-
项目类别:
-
资助金额:$16.38万
-
财政年份:1989
-
负责人:MICHAEL A FORTE
-
依托单位:
G PROTEINS IN THE CNS
-
批准号:3414061
-
项目类别:
-
资助金额:$15.6万
-
财政年份:1989
-
负责人:MICHAEL A FORTE
-
依托单位: